Ticker LaunchIPO · UPB
Upstream Bio, Inc.
Upstream Bio, Inc. (UPB) priced its initial public offering on Oct 11, 2024 at $17.00 per share, within its $15.00–$17.00 range, raising $255M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $872.8M. Cooley advised the underwriters.
- Status
- IPO
- Ticker
- UPB
- Exchange
- Nasdaq Global Select
- Priced
- Oct 11, 2024
- IPO price
- $17.00
- Price range
- $15.00–$17.00
- Raised
- $255M
- Market cap at IPO price
- $872.8M
- First filed
- Sep 18, 2024
- Underwriters' counsel
- Cooley
- Sector
- Biotech & pharma
- Country / state
- MA
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Sep 18, 2024
- Latest amendment Oct 7, 2024
- Final prospectus (424B4) Oct 11, 2024
- All filings on EDGAR CIK 2022626
Other Biotech & pharma IPOs in 2024
- Septerna, Inc.SEPN · Oct 25, 2024 · $288M
- Gelteq LtdGELS · Oct 22, 2024
- Camp4 Therapeutics CorpCAMP · Oct 11, 2024
- BioAge Labs, Inc.BIOA · Sep 26, 2024 · $198M
- Kairos Pharma, LTD.KAPA · Sep 17, 2024 · $6.2M
- Bicara Therapeutics Inc.BCAX · Sep 13, 2024 · $315M